Shi-Qi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shi-Qi Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Guang-Zhao Wang
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
2 shared publicationsWen-Bo Zhu
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
2 shared publicationsHan-Bin Zhao
The First Clinical Medical College, Henan University of Chinese Medicine, Henan, China
1 shared publication- Han-Bin Zhao
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publication Wan-Yu Ba
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publicationZu-Long Wang
Department of Andrology, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publication
Latest Publications
- Open Access
- 31 January 2026
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 18
Advances in the diagnosis and treatment of oligoasthenozoospermia based on epigenetic regulation
Male infertility accounts for a substantial proportion of global infertility, yet its molecular basis remains incompletely defined. Emerging evidence implicates epigenetic dysregulation in impaired spermatogenesis and abnormal sperm function. We synthesize genomic, transcriptomic, and single-cell studies to clarify how DNA methylation, histone modifications, and noncoding RNAs contribute to oligoasthenozoospermia. We also appraise single-cell RNA sequencing, single-cell assay for transposase-accessible chromatin using sequencing, and integrative multi-omics for resolving cell-type and stage-specific regulation. These approaches resolve germ-cell lineages, map gene-regulatory networks, and link chromatin states with transcription across spermatogenesis. Finally, we discuss translational implications for diagnostics, biomarkers, and therapeutic strategies, including antioxidant regimens, varicocele management, and assisted reproductive technologies outcomes. In conclusion, integrating epigenetics with single-cell technologies has enhanced our understanding of male germ cell development and identified potential research directions to improve reproductive health.
- 31 January 2026
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 18
Open AccessAdvances in the diagnosis and treatment of oligoasthenozoospermia based on epigenetic regulation
Male infertility accounts for a substantial proportion of global infertility, yet its molecular basis remains incompletely defined. Emerging evidence implicates epigenetic dysregulation in impaired spermatogenesis and abnormal sperm function. We synthesize genomic, transcriptomic, and single-cell studies to clarify how DNA methylation, histone modifications, and noncoding RNAs contribute to oligoasthenozoospermia. We also appraise single-cell RNA sequencing, single-cell assay for transposase-accessible chromatin using sequencing, and integrative multi-omics for resolving cell-type and stage-specific regulation. These approaches resolve germ-cell lineages, map gene-regulatory networks, and link chromatin states with transcription across spermatogenesis. Finally, we discuss translational implications for diagnostics, biomarkers, and therapeutic strategies, including antioxidant regimens, varicocele management, and assisted reproductive technologies outcomes. In conclusion, integrating epigenetics with single-cell technologies has enhanced our understanding of male germ cell development and identified potential research directions to improve reproductive health.
- Open Access
- 19 November 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 147
The effects of testicular aging on Leydig cells and the application of stem cells in restoring Leydig cells function
With the global population aging at an accelerated pace, testicular aging and its associated male health issues have garnered increasing attention. Testicular aging encompasses both age-related physiological decline and premature or pathological aging caused by various pathogenic factors. It is primarily characterized by reduced androgen secretion (mainly testosterone) and impaired spermatogenesis. Leydig cells, the key cells in the testes responsible for synthesizing and secreting testosterone, play a critical role in maintaining testicular function, and their dysfunction is one of the major contributors to testicular functional decline. In recent years, stem cell technology has demonstrated significant potential in restoring Leydig cell function. Stem cells possess the ability to differentiate into Leydig-like cells, which can restore testosterone secretion, improve the testicular microenvironment, and promote the regeneration of endogenous Leydig cells. Currently, various types of stem cells, such as stem leydig cells, mesenchymal stem cells, and induced pluripotent stem cells, have been successfully directed to differentiate into Leydig-like cells. This article provides an in-depth analysis of the mechanisms by which testicular aging affects Leydig cells, with a particular focus on the application of stem cell technology in restoring Leydig cell function. Additionally, it explores potential strategies to address these issues, aiming to offer novel perspectives and approaches for the prevention and treatment of testicular aging.
- 19 November 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 147
Open AccessThe effects of testicular aging on Leydig cells and the application of stem cells in restoring Leydig cells function
With the global population aging at an accelerated pace, testicular aging and its associated male health issues have garnered increasing attention. Testicular aging encompasses both age-related physiological decline and premature or pathological aging caused by various pathogenic factors. It is primarily characterized by reduced androgen secretion (mainly testosterone) and impaired spermatogenesis. Leydig cells, the key cells in the testes responsible for synthesizing and secreting testosterone, play a critical role in maintaining testicular function, and their dysfunction is one of the major contributors to testicular functional decline. In recent years, stem cell technology has demonstrated significant potential in restoring Leydig cell function. Stem cells possess the ability to differentiate into Leydig-like cells, which can restore testosterone secretion, improve the testicular microenvironment, and promote the regeneration of endogenous Leydig cells. Currently, various types of stem cells, such as stem leydig cells, mesenchymal stem cells, and induced pluripotent stem cells, have been successfully directed to differentiate into Leydig-like cells. This article provides an in-depth analysis of the mechanisms by which testicular aging affects Leydig cells, with a particular focus on the application of stem cell technology in restoring Leydig cell function. Additionally, it explores potential strategies to address these issues, aiming to offer novel perspectives and approaches for the prevention and treatment of testicular aging.